AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ENOXAPARIN SODIUM
65 registrations across 9 African markets— 57 active
Markets with ENOXAPARIN SODIUM
🇿🇦South Africa
15 registrations
10 active
🇺🇬Uganda
14 registrations
14 active
🇿🇼Zimbabwe
11 registrations
11 active
🇷🇼Rwanda
6 registrations
4 active
🇬🇭Ghana
6 registrations
6 active
🇨🇮Côte d'Ivoire
4 registrations
3 active
🇳🇬Nigeria
4 registrations
4 active
🇰🇪Kenya
3 registrations
3 active
🇹🇿Tanzania
2 registrations
2 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CLEXANE 4000IU SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE (ENOXAPARIN SODIUM 40MG/0.4ML) | 🇬🇭Ghana | — | active | Feb 2031 |
| CLEXANE 4000IU SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE (ENOXAPARIN SODIUM 40MG/0.4ML) | 🇬🇭Ghana | — | active | Feb 2031 |
| EXAPINE SOLUTION; INJECTION | 🇿🇼Zimbabwe | ORANGE HEALTH P/L | active | Feb 2031 |
| CLOTEX 40 Solution For Injection | 🇰🇪Kenya | The SAY Pharma Drug store LLC, | active | Jul 2030 |
| Muditin 40 Injection** Solution for injection | 🇳🇬Nigeria | Ignite Pharma Nigeria Limited | active | Jun 2030 |
| Clerin 40 mg/0.4 mL** Solution for injection | 🇳🇬Nigeria | Malven Medics International Company Ltd | active | May 2030 |
| GMOPAR | 🇬🇭Ghana | — | active | Mar 2030 |
| GMOPAR | 🇬🇭Ghana | — | active | Mar 2030 |
| IVENOXIN 80 | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Feb 2030 |
| IVENOXIN 100 | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Feb 2030 |
| IVENOXIN 20 | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Feb 2030 |
| IVENOXIN 40 | 🇿🇦South Africa | KAHMA BIOTECH (Pty) Ltd | active | Feb 2030 |
| LOMOH 40 SOLUTION FOR INJECTION | 🇷🇼Rwanda | EMCURE PHARMACEUTICALS LIMITED | active | Jan 2030 |
| EXAPINE SOLUTION; INJECTION | 🇿🇼Zimbabwe | ORANGE HEALTH P/L | active | Aug 2028 |
| EXAPINE SOLUTION; INJECTION | 🇿🇼Zimbabwe | ORANGE HEALTH P/L | active | Aug 2028 |
| ENOXAPARIN SODIUM SOLUTION; INJECTION | 🇿🇼Zimbabwe | ARAVAS PHARMACEUTICALS | active | Aug 2028 |
| ENOXAPARIN SODIUM SOLUTION; INJECTION | 🇿🇼Zimbabwe | ARAVAS PHARMACEUTICALS | active | Aug 2028 |
| Cutenox Injection 20 mg/0.2 mL** Solution for injection | 🇳🇬Nigeria | Fidson Healthcare PLC | active | Jul 2028 |
| ENOXA 2000 UI, ANTI-XA/0.2ML Solution for Injection | 🇷🇼Rwanda | — | active | May 2028 |
| ENOXA 6000 UI, ANTI-XA/0.6ML Solution for Injection | 🇷🇼Rwanda | — | active | May 2028 |
| ENOXA 8000 UI, ANTI-XA/0.8ML Solution for Injection | 🇷🇼Rwanda | — | active | May 2028 |
| Clexane Injectable Solution 6000 IU** Solution for injection | 🇳🇬Nigeria | Sanofi-Aventis Nigeria Limited | active | Feb 2028 |
| LOMOH-40 INJECTABLE; INJECTION | 🇿🇼Zimbabwe | EMCURE PHARMACEUTICALS LTD | active | Dec 2027 |
| LOMOH 80 SOLUTION; INJECTION | 🇿🇼Zimbabwe | EMCURE PHARMACEUTICALS LTD | active | Dec 2027 |
| LOMOH 60 SOLUTION; INJECTION | 🇿🇼Zimbabwe | EMCURE PHARMACEUTICALS LTD | active | Dec 2027 |
| ENOPAXARIN SODIUM IMPACT INJECTABLE; INJECTION | 🇿🇼Zimbabwe | SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD | active | Dec 2027 |
| ENOXAPARIN SODIUM IMPACT INJECTABLE; INJECTION | 🇿🇼Zimbabwe | SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD | active | Dec 2027 |
| ENOXAPARIN SODIUM IMPACT INJECTABLE; INJECTION | 🇿🇼Zimbabwe | SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD | active | Dec 2027 |
| Clotinex 40 Pre-Filled Syringe Injection Solution For Injection In Pre-Filled Syringe | 🇰🇪Kenya | Square Pharmaceuticals Ltd. | active | Sept 2027 |
| Clotinex 60 Pre-filled Syringe injection Injection | 🇰🇪Kenya | Square Pharmaceuticals Ltd | active | Sept 2027 |
| LOMOH-40 INJECTION (Each 0.4ml contains Enoxaparin Sodium 40mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| LOMOH-40 INJECTION (Each 0.4ml contains Enoxaparin Sodium 40mg) | 🇬🇭Ghana | — | active | Dec 2026 |
| ENOXAPARIN SODIUM SOLUTION FOR INJECTION | 🇷🇼Rwanda | POOYESH DAROU BIO PHARMACEUTICAL CO. | expired | Jun 2026 |
| ENOXAPARIN SODIUM SOLUTION FOR INJECTION | 🇷🇼Rwanda | POOYESH DAROU BIO PHARMACEUTICAL CO. | expired | Mar 2026 |
| CLEXIWIN 300 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Dec 2024 |
| CLEXIWIN 60 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Dec 2024 |
| CLEXIWIN 40 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Dec 2024 |
| CLEXIWIN 20 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Dec 2024 |
| CLEXIWIN 80 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | suspended | Dec 2024 |
| LOVENOX 6000 IU SOLUTION INJECTABLE BOITE DE 2 | 🇨🇮Côte d'Ivoire | SANOFI WINTHROP INDUSTRIE, GENTILLY, 82 AVENUE RASPAIL | expired | Aug 2022 |
| NOXFIBRA 40 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| NOXFIBRA 60 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| CLEXANE 60 | 🇿🇦South Africa | Sanofi-Aventis South Africa (Pty) Ltd | active | Jan 1900 |
| NOXFIBRA 20 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| NOXFIBRA 80 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| NOXFIBRA 100 | 🇿🇦South Africa | Sandoz South Africa (Pty) Ltd | active | Jan 1900 |
| ENOXAPARIN
SODIUM PARENTERAL
ORDINARY PRE-
FILLED SYRINGES | 🇺🇬Uganda | BRAWN LABORATORIES LTD | active | — |
| ENOLEX Solution for Injection | 🇹🇿Tanzania | MORAF PHARMACEUTICALS LTD | active | — |
| ENOLEX Solution for Injection | 🇹🇿Tanzania | MORAF PHARMACEUTICALS LTD | active | — |
| LOVENOX 8000 IU SOLUTION INJECTABLE BOITE DE 2 | 🇨🇮Côte d'Ivoire | SANOFI WINTHROP INDUSTRIE, GENTILLY, 82 AVENUE RASPAIL | active | — |
Showing 50 of 65 registrations. Sign up free to search and export all.
ENOXAPARIN SODIUM in Africa — Regulatory Overview
ENOXAPARIN SODIUM is registered across 9 African markets with 65 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Uganda, Zimbabwe, Rwanda and 5 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 65 registrations, 57 (88%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.